Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
Sebastian Eduardo Sattui, Richard P. Conway, R C Conway, Michael Putman et autres
BACKGROUND: Patients with primary systemic vasculitis or polymyalgia rheumatica might be at a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ damage cause by primary systemic vasculitis, and the demographic factors associated with these conditions. We …
us, ie, au, gb, ar, br, se, it, fr, de, pt, qa, pe, es, ca, nz (code pays fourni par la source)
51 citations
The Lancet Rheumatology